News and Events
Spreading Knowledge, Not Disease at IDWeek 2025
Friday, November 7, 2025
DOM had a strong showing at IDWeek 2025, a major annual gathering of over 10,000 infectious diseases experts. Physicians, pharmacists, researchers, and trainees in the Infectious Diseases Division shared their knowledge at the conference via workshops, posters, and oral presentations addressing some of the field’s most pressing challenges.
Check out the fascinating (and sometimes gross) work they shared.
Workshops and Presentations
Brenda Tesini, MD, poses with a poster for her presentation.
Affiliated Session: Advancing RSV Vaccination in Older Adults: Empowering Experts to be Advocates
Presented by Brenda Tesini, MD, of Infectious Diseases
Workshop: Pus, Slough, and Drainage: Oh My! Hands-on Introduction to Wound Care
Moderated by Ted Louie, MD, of Infectious Diseases
Affiliated Session: RSV is Only Half the Story: Uncovering Human Metapneumovirus (hMPV) Burden in Adult
Moderated by Ed Walsh, MD, of Infectious Diseases
Affiliated Session: Impact on ID Quality from Changes in Federal Regulations and Resource
Presented by Alexandra Yamshchikov, MD
Presentation: A Growing Threat: The Rising Incidence of ESBL-E Infections Among Pediatric Patients in Monroe Co, NY
Presented by Hsioa Che “Kiki” Looi, MPH, of the Center for Community Health & Prevention (CCHP)
DOM coauthors: Brenda Tesini, MD, and Ghinwa Dumyati, MD, of Infectious Diseases
Presentation: Safety, Tolerability, and Immunogenicity of the mRNA-1345 RSV Vaccine in Solid Organ Transplant Recipients Aged ≥18 Years
Presented by Eric Mayer, MD, of Moderna DOM co-authors: Ann Falsey, MD, of Infectious Diseases
Posters
From left: Paulina Sudnik, MD, Ghinwa Dumyati, MD, and Colin Samoriski, MD, at
IDWeek in Atlanta, GA.
Poster (Quality Improvement): A Clinical Management Algorithm Using Society for Vascular Surgery Wound, Ischemia, and Foot Infection (WIfI) Score in Emergency Departments (ED) for Lower Extremity Wounds (LEW) Improves Diagnostic Efficiency and Resource Allocation, Implications for Quality Improvement (QI)
Presented by Colin Samoriski, MD, of Infectious Diseases, who won a travel award for the poster
Coauthors: Christine Kim, MD, Internal Medicine resident, Ted Louie, MD, of Infectious Diseases, and Alexandra Yamshchikov, MD, of Infectious Diseases
Poster (Social Determinants of Health): Social Determinants of Health (SDOH) are Associated with Non-Intravascular Device (IVAD) Related Adverse Events (AE) in Patients Treated with Outpatient Parenteral Antimicrobial Therapy (OPAT)
Presented by Colin Samoriski, MD, of Infectious Diseases DOM coauthors: Alexandra Yamshchikov, MD, of Infectious Diseases, and Mike Sportiello, MD, PhD, a recent UR SMD graduate
Ghinwa Dumyati, MD, poses with her poster.
Poster (Respiratory Infections): Why Aren't We Treating? Reasons for Antiviral Non-Prescription in Hospitalized Children with Influenza
Presented by Christina Felsen, MPH, of CCHP
DOM coauthors: Brenda Tesini, MD, and Ghinwa Dumyati, MD, of Infectious Diseases
Poster (Health Care-Associated Infections): Real World Effectiveness of Fidaxomicin in Preventing Recurrence of Initial Community-Associated C difficile Infection
Presented by Christopher Myers, MS, of CCHP DOM coauthor: Ghinwa Dumyati, MD, of Infectious Diseases
Poster (Health Care-Associated Infections): Mupirocin Resistance Among Methicillin-Resistant Staphylococcus aureus Surveillance Isolates Associated with Invasive Infections, 2005-2022
Presented by Holly Biggs, MD, MPH, of the Centers for Disease Control & Preventions
DOM Coauthor: Ghinwa Dumyati, MD, of Infectious Diseases
Poster (Antibiotic Stewardship): Clinician Alert Interactions and Antibiotic Exposure in Beta-Lactam Allergic Patients following Suppression of Beta Lactam Antibiotic (BLA) Cross-Sensitivity Alerts (CSAs) in the Electronic Health Record (EHR): A Need for Balancing Measures
Presented by Alexandra Yamshchikov, MD, of Infectious Diseases
DOM coauthors: Jessica Stern, MD, of Allergy, Immunology, and Rheumatology, David Dobrzynski, MD, of Infectious Diseases, and ID Clinical Pharmacists Katelyn Quartuccio, PharmD, Stephanie Shuler, PharmD, and Sarah Spitznogle, PharmD
From left: Sonal Munsiff, MD, Alexandra Yamshchikov, MD, Jennifer Wachala, MD,
Paul Bohjanen, MD, PhD, Edward Walsh, MD, and Ted Louie, MD, out for a team dinner.
Poster (Respiratory Infections): Differentially Expressed Genes in Patients with Legionella and Streptococcus Pneumonia
Presented by Paulina Sudnik, MD, of Infectious Diseases DOM coauthors: Ed Walsh, MD, Angela Branche, MD, Ann Falsey, MD, of Infectious Diseases
Poster (Bone and Joint): Epidemiology, Clinical Characteristics, and Outcomes of Patients with Nontuberculous Mycobacterial Bone and Joint Infections at the University of Rochester Medical Center, New York from 2019-2023
Presented by Patrick Passarelli, MD, a recent ID fellowship graduate
DOM coauthors: Michael Croix, MD, Alok Gupta, MBBS, and Sonal Munsiff, MD, of Infectious Diseases
Poster (Antibiotic Stewardship): Impact of Social Determinants of Health on Synchronous and Asynchronous Antibiotic Prescribing Practices: Quality Improvement Experience of a Large Primary Care Network
Presented by Mike Sportiello, MD, PhD, a recent UR SMD graduate
DOM coauthors: Robert Fortuna, MD, MPH, of Primary Care, and Alexandra Yamshchikov, MD, of Infectious Diseases
URMC Joins National Network for Bronchiectasis and NTM Care
Friday, March 14, 2025
Alexandra Adams, MD
Sonal Munsiff, MDThe Medical Center is among 33 centers across the country selected for the Bronchiectasis and NTM Care Center Network. URMC was named a Clinical Associate Center, the only site in Upstate New York, supporting specialized care for bronchiectasis and nontuberculous mycobacterial (NTM).
Sonal S. Munsiff, MD, of Infectious Diseases, and Alexandra Adams, MD, of Pulmonary Diseases and Critical Care, are co-directors of the center.
“We are proud to be part of the first national network for the treatment of these highly complex lung infections,” said Munsiff. “This national designation is a testament to our leadership in providing outstanding patient care and in conducting cutting-edge research in lung diseases.”
The network aims to develop standards of care that can be implemented across different centers, reduce the diagnosis time and support high-quality care.
“This designation will provide us greater access to clinical research trials to treat these conditions and help improve the standards of care for bronchiectasis and NTM patients across Central and Western New York,” Adams said.
More than 300,000 people in the United States are treated for bronchiectasis each year. It is characterized by enlarged airways that are thickened or scarred, making it difficult to clear mucus buildup. NTM is a chronic condition caused by mycobacteria and impacts people with compromised immune systems or other lung conditions, like bronchiectasis or COPD.
Network centers will create a national registry of patients, which will help management of the diseases and improve patient outcomes. The teams are working to establish a registry in the EMR to track bronchiectasis and NTM patients and support research.